Daniel Wells
Daniel Wells
Genomics plc
Verified email at genomicsplc.com - Homepage
Title
Cited by
Cited by
Year
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
NK Alharbi, E Padron-Regalado, CP Thompson, A Kupke, D Wells, ...
Vaccine 35 (30), 3780-3788, 2017
1192017
Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
VJ Munster, D Wells, T Lambe, D Wright, RJ Fischer, T Bushmaker, ...
npj Vaccines 2 (1), 1-4, 2017
562017
Unified single-cell analysis of testis gene regulation and pathology in five mouse strains
M Jung, D Wells, J Rusch, S Ahmad, J Marchini, SR Myers, DF Conrad
Elife 8, e43966, 2019
52*2019
Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo
RM Williams, U Senanayake, M Artibani, G Taylor, D Wells, AA Ahmed, ...
Development 145 (4), dev160333, 2018
442018
ZCWPW1 is recruited to recombination hotspots by PRDM9 and is essential for meiotic double strand break repair
D Wells, E Bitoun, D Moralli, G Zhang, A Hinch, J Jankowska, P Donnelly, ...
Elife 9, e53392, 2020
162020
Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries
ME Weale, F Riveros-Mckay, S Selzam, P Seth, R Moore, WA Tarran, ...
The American Journal of Cardiology 148, 157-164, 2021
62021
Delineation of meiotic gene expression in male mice
D Wells
University of Oxford, 2020
2020
Vaccines for Tumours: Melanoma
D Wells
Authorea Preprints, 2017
2017
Case Commentary: Severe Combined Immune Deficiencies
D Wells
2015
The system can't perform the operation now. Try again later.
Articles 1–9